Skip to content

Alligator Bioscience

  •  
    • Se
  • Startpage
  • About Alligator
    • Board of Directors
    • Senior Management
    • Career
  • Research and development
    • Immunotherapy of cancer
    • Pipeline
      • Mitazalimab
      • ATOR-4066
      • ALG.APV-527
      • HLX22
    • Scientific publications
    • Scientific advisors
  • Corporate governance
    • General meeting
    • Board of Directors and Management
    • Nomination Committee
    • Audit Committee
    • Remuneration Committee
    • Remuneration
    • Auditors
    • Articles of association
    • Internal control
  • Investors
    • Share and owner information
    • Sharegraph
    • Analysts
    • Corporate deck
    • Capital raisings
      • Preferential Rights Issue Q4 2025
    • Financial reports
      • Interim reports
      • Year End Reports
      • Annual reports
    • Financial calendar
    • Presentations
  • Business Development
  • Press releases
  • Contact
  • Events

  1. Startpage
  2. Calendar
  3. List
Key downloads
Alligator Bioscience publishes Annual Report for 2025Alligator Bioscience AB reports full year financial results for 2025 and for Q4 2025 and provides a business updateBulletin from the extraordinary general meeting in Alligator Bioscience ABAlligator Bioscience AB reports financial results for Q3 2025 and provides a business updateAlligator Bioscience AB reports financial results for Q2 2025 and provides a business update
12 events found.

Investor events

  1. Events
  2. Investor events

Events

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
  • Day
Today
  • June 2022

  • Wed 8

    BioStock Life Science Spring Summit

    8 June, 2022 - 9 June, 2022
  • November 2022

  • Tue 15

    Jefferies London Healthcare Conference 2022

    15 November, 2022 - 17 November, 2022
    London London, Storbritannien (Förenade kungariket Storbritannien)
  • Thu 24

    Redeye Life Science Day, Stockholm

    24 November, 2022
    Virtuellt

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • Wed 30

    Biostock Life Science Fall Summit 2022

    30 November, 2022 @ 13:00 - 13:30
    Medicon Village Medicon Village, Lund, Sverige

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.

  • December 2022

  • Thu 15

    13th Annual DNB Nordic Healthcare Conference

    15 December, 2022
    Oslo Oslo, Norge

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • January 2023

  • Mon 9

    41st Annual J.P. Morgan Healthcare Conference

    9 January, 2023 - 12 January, 2023
  • Thu 19

    Redeye Fight Cancer Day 2023

    19 January, 2023
    Redeye Mäster Samuelsgatan 42, Stockholm, Sverige
  • Tue 31

    Aktiespararna “Aktiedagen i Lund”

    31 January, 2023
    Elite Hotel Ideon Scheelevägen 27, Lund, Sverige
  • February 2023

  • Wed 22

    ØU Life Science Investor Conference

    22 February, 2023
    Köpenhamn Köpenhamn, Danmark

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • November 2023

  • Mon 13

    Inv€$tival Showcase

    13 November, 2023 @ 11:30 - 11:45
    Old Billingsgate 1 Old Billingsgate Walk, 16 Lower Thames, London, Storbritannien (Förenade kungariket Storbritannien)
  • Tue 14

    Jefferies London Healthcare Conference

    14 November, 2023 - 16 November, 2023
    Waldorf Hilton (Aldwych) Aldwych, London, Storbritannien (Förenade kungariket Storbritannien)
  • Wed 22

    ØU Life Science Investor Konference

    22 November, 2023 @ 16:15 - 16:30
    Copenhagen Copenhagen, Danmark
  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
  1. Startpage
  2. Calendar
  3. List
About Alligator

Alligator, a clinical-stage biotechnology company, develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.

Alligator Bioscience has global headquarters in Lund, Sweden, and is listed on Nasdaq Stockholm (ticker: ATORX).

Links
  • About Alligator
  • R&D
  • Corporate governance
  • Investors
  • News
  • Business Development
  • Privacy Policy
  • Glossary
Contact us

Headquarter
Alligator Bioscience AB
Medicon Village
Scheeletorget 1
SE-223 81 Lund Sweden

Phone:
+ 46 (0)46 540 82 00

info@alligatorbioscience.com
ir@alligatorbioscience.com
bd@alligatorbioscience.com

Follow us

  

Email subscription

Subscribe to get our pressreleases and investor alerts by email from Alligator Bioscience.

Subscribe

  • © Copyright 2024 – Alligator Bioscience AB

  • Privacy Policy | Use of Cookies |  Change your cookie settings here.

  • Disclaimer Market data could be delayed. Delivered by Modular Finance.

Cookies
We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.
Settings Accept all
Cookies
Do your settings below. Or read our cookie policy.
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all